北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (3): 522-526. doi: 10.3969/j.issn.1671-167X.2017.03.025

• 论著 • 上一篇    下一篇

PTCH1基因突变对牙源性角化囊性瘤上皮细胞增殖的影响

司马梓涵,洪瑛瑛,李铁军△   

  1. (北京大学口腔医学院·口腔医院, 病理科口腔数字化医疗技术和材料国家工程实验室口腔数字医学北京市重点实验室, 北京100081)
  • 出版日期:2017-06-18 发布日期:2017-06-18
  • 通讯作者: 李铁军 E-mail: litiejun22@vip.sina.com
  • 基金资助:
     国家自然科学基金(81671006、81030018)资助

Effects of PTCH1 mutations on the epithelial proliferation derived from keratocystic odontogenic tumour

SIMA Zi-han, HONG Ying-ying, LI Tie-jun△   

  1. (Department of Oral Pathology, Peking University School and Hospital of Stomatology & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China)
  • Online:2017-06-18 Published:2017-06-18
  • Contact: LI Tie-jun E-mail: litiejun22@vip.sina.com
  • Supported by:
    Supported by the National Natural Science Foundation of China (81671006, 81030018)

摘要:  目的:研究牙源性角化囊性瘤(keratocystic odontogenic tumour, KCOT)中PTCH1基因突变与上皮细胞中bcl2、丝聚合蛋白和兜甲蛋白表达的关系,探讨PTCH1基因突变对肿瘤上皮细胞增殖、分化的影响。方法:采用PCR直接测序法筛选出有PTCH1基因突变的KCOT患者及无突变者各20例,用免疫组织化学方法检测上皮细胞增殖相关蛋白bcl2、丝聚合蛋白、兜甲蛋白在KCOT上皮细胞中的表达情况。结果:20例PTCH1基因发生突变的KCOT患者中,bcl2强阳性12例(12/20, 60%)、中度阳性4例(4/20, 20%)、弱阳性4例(4/20, 20%),非突变组中强阳性4例(4/20, 20%)、弱阳性10例(10/20, 50%)、阴性6例(6/20, 30%),两组之间差异有统计学意义(U=72, P=0.001)。丝聚合蛋白表达于上皮浅层1~4层细胞,突变组中丝聚合蛋白表达弱阳性11例(11/20, 55%)、阴性9例(9/20, 45%),未见强阳性和中度阳性表达,非突变组中丝聚合蛋白表达中度阳性6例(6/20, 30%)、弱阳性8例(8/20, 40%)、阴性6例(6/20, 30%),无强阳性表达病例,两组之间差异无统计学意义(U=182,P=0.48)。兜甲蛋白在突变组和非突变组KCOT衬里上皮细胞全层均呈阳性表达,两组差异无统计学意义。结论:PTCH1基因突变与KCOT肿瘤上皮细胞中bcl2蛋白的表达水平相关,提示PTCH1基因突变可能促进肿瘤上皮细胞的增殖和分化。

关键词: 牙源性肿瘤, PTCH1基因, 突变, 细胞增殖

Abstract: Objective: To explore the relationship between the PTCH1 mutation and the expression of bcl-2, filaggrin, and loricrin in the keratocystic odontogenic tumour (KCOT), as well as the effects of the mutated PTCH1 on the epithelial proliferation and differentiation. Methods: The samples were collected from 20 cases of KCOT with mutated PTCH1, as well as 20 cases without mutation. All the samples were analyzed with immunohistochemical staining, for the purpose of investigating the expression of bcl-2, filaggrin, and loricrin. Results: In the samples with mutated PTCH1, the epithelia of 60% (12/20) cases expressed intensively positive bcl-2 staining, 20% (4/20) expressed moderate staining, and 20% (4/20) weak staining, but no negative bcl-2 staining samples were investigated; it was significantly different from the samples without PTCH1 mutation, in which 20% (4/20) expressed intensive staining, no moderate staining, 50% (10/20) weak staining, and 30% (6/20) negative staining were investigated (U=72, P=0.001). For the expression of filaggrin, 55% (11/20) of samples with PTCH1 mutations were stained weakly and 45% (9/20) showed negative staining, while in the samples not harboring PTCH1 mutations, 30% (6/20) cases showed moderate positive staining, 40% (8/20) weak staining and 30% (6/20) negative staining, no intensive staining was investigated (U=182, P=0.48). The loricrin expressed in all the layer of the epithelia in all the samples, while the filaggrin was mainly loca-lized within 1-4 layer cells of the epithelia. The differences of the expression of filaggrin and loricrin between the samples with mutated PTCH1 and without mutated PTCH1 displayed no significance. Conclusion: In the epithelia of KCOT, the bcl-2 expression was significantly associated with the PTCH1 mutation, which suggested that the mutated PTCH1 gene perhaps promotes the proliferation of KCOT epithelium.

Key words: Odontogenic tumors, PTCH1 gene, Mutation, Cell proliferation

中图分类号: 

  • R780.2
[1] 张瑶,郭金鑫,战世佳,洪恩宇,杨慧,贾安娜,常艳,郭永丽,张璇. 富含半胱氨酸和甘氨酸蛋白2在神经母细胞瘤恶性进展中的功能和机制[J]. 北京大学学报(医学版), 2024, 56(3): 495-504.
[2] 时云飞,王豪杰,刘卫平,米岚,龙孟平,刘雁飞,赖玉梅,周立新,刁新婷,李向红. 血管免疫母细胞性T细胞淋巴瘤临床与分子病理学特征分析[J]. 北京大学学报(医学版), 2023, 55(3): 521-529.
[3] 熊焰,张波,聂立功,吴世凯,赵虎,李东,邸吉廷. 胸部SMARCA4缺失性未分化肿瘤的病理诊断与联合免疫检测点抑制剂治疗[J]. 北京大学学报(医学版), 2023, 55(2): 351-356.
[4] 周秋君,龚潘,焦莶如,杨志仙. 1例Angelman综合征合并眼皮肤白化病2型患者的临床和遗传学分析及文献回顾[J]. 北京大学学报(医学版), 2023, 55(1): 181-185.
[5] 刘媛,原婉琼,李婷,王平章,吕平,吴利新,阮国瑞,韩文玲,莫晓宁. 敲减CMTM3增加急性B淋巴细胞白血病细胞对伊马替尼敏感性[J]. 北京大学学报(医学版), 2022, 54(6): 1238-1243.
[6] 程晓静,蒋栋,张连海,王江华,李雅真,翟佳慧,闫宝琪,张露露,谢兴旺,李子禹,季加孚. KRAS G12V特异性T细胞受体治疗恶性肿瘤的临床前研究[J]. 北京大学学报(医学版), 2022, 54(5): 884-895.
[7] 秦彩朋,宋宇轩,丁梦婷,王飞,林佳兴,杨文博,杜依青,李清,刘士军,徐涛. 肾癌免疫治疗疗效评估突变预测模型的建立[J]. 北京大学学报(医学版), 2022, 54(4): 663-668.
[8] 陈曦,王斯悦,薛恩慈,王雪珩,彭和香,范梦,王梦莹,武轶群,秦雪英,李劲,吴涛,朱洪平,李静,周治波,陈大方,胡永华. 基于核心家系全外显子组测序数据探索新生突变与非综合征型唇腭裂的关联[J]. 北京大学学报(医学版), 2022, 54(3): 387-393.
[9] 曹泽,王乐童,刘振明. 严重急性呼吸综合征冠状病毒2的Spike蛋白点突变后与受体蛋白质及潜在抗病毒药物结合能力的同源建模分析[J]. 北京大学学报(医学版), 2021, 53(1): 150-158.
[10] 吴君怡,余淼,孙仕晨,樊壮壮,郑静蕾,张刘陶,冯海兰,刘洋,韩冬. 少汗性外胚层发育不良患者EDA基因突变检测及表型分析[J]. 北京大学学报(医学版), 2021, 53(1): 24-33.
[11] 鲍轶,莫娟芬. 同时性多原发肺腺癌组织编码转录因子ERG基因相同位点突变1例报告[J]. 北京大学学报(医学版), 2020, 52(5): 971-974.
[12] 谢静,赵玉鸣,饶南荃,汪晓彤,方滕姣子,李晓霞,翟越,李静芝,葛立宏,王媛媛. 3种口腔颌面部来源的间充质干细胞成血管内皮分化潜能的比较研究[J]. 北京大学学报(医学版), 2019, 51(5): 900-906.
[13] 张宽根,周雨禾,邵雅昆,梅放,由江峰,刘北英,裴斐. 肿瘤转移抑制基因LASS2/TMSG1 S248A突变体通过增加ATP6V0C表达促进前列腺癌的侵袭[J]. 北京大学学报(医学版), 2019, 51(2): 210-220.
[14] 王皓,刘洋,刘浩辰,韩冬,冯海兰. 先天性缺牙患者中BMP2基因突变检测及功能分析[J]. 北京大学学报(医学版), 2019, 51(1): 9-15.
[15] 尤柱,徐丽莉,李雪芬,张建运,杜菁,孙丽莎. 成釉细胞纤维瘤中BRAF突变基因的检测[J]. 北京大学学报(医学版), 2019, 51(1): 4-5.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!